TYVASO DPI

Indicated For

Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD)

About This Medication

# United Therapeutics Cares Co-Pay Assistance Program Patient Guide: How to Get TYVASO DPI at Low or No Cost TYVASO DPI (treprostinil) is an inhaled medication used to treat pulmonary arterial hypertension (PAH) and certain types of interstitial lung disease (ILD). The **United Therapeutics Cares Co-Pay Assistance Program** helps eligible patients with **commercial insurance** pay as little as **$0 co-pay** per prescription, covering the cost of the drug up to an annual maximum benefit.[1][2][3] ## About TYVASO DPI **TYVASO DPI** is a dry powder inhaler form of treprostinil, a prostacyclin analog that helps relax blood vessels in the lungs to improve blood flow and reduce symptoms of PAH or PH-ILD. Unlike the nebulized version (TYVASO), the DPI version is portable and doesn't require mixing solutions, making it easier for daily use—typically 4 times a day.[1][2] It's prescribed for FDA-approved uses and delivered only through specialty pharmacies like **Accredo** or **CVS Specialty**.[2] This guide focuses on the Co-Pay Assistance Program, but note there's also a separate **Patient Assistance Program (PAP)** for uninsured or underinsured patients—call (844) 864-8437 to check eligibility.[4][8] ## Who Qualifies? This program is designed for patients with **private commercial insurance** facing high out-of-pocket costs. Key requirements include: - U.S. resident (including Puerto Rico, subject to state restrictions).[5] - Valid prescription for TYVASO DPI for an **FDA-approved indication**.[3][8] - **Commercial (private) insurance** only—no government programs.[1][3] - Not combining with other discounts, coupons, or savings offers.[3] **Important:** No specific income thresholds are listed for the co-pay program, making it accessible regardless of income as long as you have qualifying insurance. However, the separate PAP has income guidelines for uninsured patients.[4][8] ## Income Eligibility Breakdown The Co-Pay Assistance Program does not impose income limits. Here's a simple overview: | Eligibility Factor | Details | |--------------------|---------| | **Income Threshold** | None required—open to all with commercial insurance. |[1][3] | **Separate PAP** | Income-based for uninsured/underinsured; contact program for details. |[4][8] | **Annual Benefit** | Covers co-pay up to a maximum (exact amount not specified; patient responsible for remainder). Program valid only for drug cost, not supplies. |[1][3] If you're uninsured, explore the PAP instead.[8] ## Insurance Requirements - **Eligible:** Commercial/private insurance plans.[1][3][4] - **Not Eligible:** Medicare, Medicaid, or any federal/state government program. If you switch to government coverage, you lose eligibility immediately.[3] - The program covers your co-pay for the medication only—not supplies, administration costs, or other expenses.[1][3] - Pharmacists/prescribers cannot seek reimbursement from insurance for the program's benefit.[3] Your specialty pharmacy and Patient Navigator will verify coverage before approval.[2] ## Step-by-Step Application Process Enrollment is straightforward with **multiple methods**. Expect support from your doctor, United Therapeutics Cares, and specialty pharmacies.[2] 1. **Talk to Your Doctor:** Ask them to send a referral/prescription to a specialty pharmacy (Accredo: 1-866-344-4874 or CVS Specialty: 1-877-242-2738) or United Therapeutics Cares.[2] 2. **Enroll in the Program:** - Visit [https://www.unitedtherapeuticscarescopay.com/enroll/tyvaso](https://www.unitedtherapeuticscarescopay.com/enroll/tyvaso) and complete the online form in a few steps.[3] - Or call **(844) 864-8437** (Mon-Fri, 8:30 am - 7 pm ET) for help from a Patient Navigator.[1][2] 3. **Verification:** Your Patient Navigator or specialty pharmacy contacts your insurer to confirm coverage and benefits. They'll review your eligibility.[2] 4. **Get Your Program ID:** Once approved, receive a unique ID (one per patient, non-transferable).[3] 5. **Prescription Fulfillment:** Specialty pharmacy coordinates delivery to your home. They'll train you on use and provide 24/7 support.[2][4] **Tip:** Answer calls from the pharmacy or support team—they'll guide you![2] ## Timeline and Delivery - **Processing:** Varies; specialty pharmacy verifies insurance quickly, often within days. Approval depends on your insurer's response.[2] - **Delivery:** Ships directly to your home via **Accredo** or **CVS Specialty**. Coordinate a convenient time; refills are managed ongoing.[2][4] - **Ongoing Support:** Regular check-ins from Patient Navigators for education, refills, and questions.[1][2][7] Exact processing time isn't specified—call for your status.[1] ## Alternatives if Denied or Ineligible - **Government Insurance:** Not eligible here, but check state Medicaid or Medicare Extra Help. - **Uninsured/Underinsured:** Apply to the **United Therapeutics ASSIST Patient Assistance Program (PAP)** for potentially free medication if you meet income guidelines and are a U.S. resident.[4][8] - **Other Resources:** Pulmonary Hypertension Association lists additional aid; explore generic options or manufacturer PAPs.[9] - **Appeal:** Contact United Therapeutics Cares to discuss denial reasons and next steps.[1] - **Charity Foundations:** Patient Access Network (PAN) or HealthWell Foundation may help with copays for PAH. ## Refills and Reauthorization Your specialty pharmacy handles refills seamlessly. Patient Navigators monitor and coordinate—no formal reauthorization details provided, but expect periodic coverage checks.[2][4] ## Disclaimer This guide is for informational purposes based on publicly available program details as of March 2026. Eligibility, benefits, and terms can change—always verify with United Therapeutics Cares at (844) 864-8437 or the official website. Not a substitute for medical or financial advice. Program not valid where prohibited by law; see full Terms & Conditions online.[1][3][5] United Therapeutics reserves the right to modify or end the program. Consult your doctor before starting TYVASO DPI.

Program information last verified: March 30, 2026